Whalesbook
Dekho, West Asia mein jo tension chal rahi hai na, usne apne pharma exports ko kaafi bada jhatka diya hai. March 2026 mein, humara pharma exports seedha 23.17% neeche gir gaya, jo pichle 5 saal ka sabse bada monthly contraction hai. Commerce Ministry ne bataya ki March 2026 mein exports $2.83 billion rahe, jo March 2025 ke $3.68 billion se kaafi kam hai. Experts ka kehna hai ki lagbhag 80-90% yeh problem demand ki nahi, balki logistics ki wajah se hui hai.
Ab yeh West Asia ka conflict kaise impact kar raha hai? Simple hai, apne exports kaafi traffic Gulf ke hubs jaise Dubai, Abu Dhabi, aur Doha se hoker jaate hain Europe, North America, aur Africa. Yeh jagah cold-chain ke liye super important hain, jahan par sensitive drugs aur vaccines store hote hain. Zara si bhi temperature ki problem ya delay shipment ko kharab kar sakta hai. Shipping companies ne toh freight charges $3,500 se $8,000 per shipment tak badha diye hain ya fir Gulf-bound cargo lena band kar diya hai. China se APIs lane ka kharcha bhi $1,200 se double hokar $2,400 per unit ho gaya. Air cargo mein bhi dikkat aa rahi hai.
Hum toh 'Pharmacy of the World' kehlata hain, global generic drugs ka 20% banate hain. Lekin yeh sab dikhata hai ki hum geopolitical risks ke liye kitne sensitive hain. Red Sea aur Strait of Hormuz jaise routes par dependence, aur transit hubs par nirbhar rehna, sab cost badha raha hai aur delivery delay kar raha hai. Upstream mein API ke liye China par dependency bhi ek factor hai.
But, don't worry! Yeh sirf ek short-term problem hai. Pure FY26 ke liye, overall exports $31.11 billion rahe, jo 2.13% zyada hai FY25 se. Industry experts ka toh kehna hai ki sector 2030 tak $130 billion tak pahunch sakta hai. Domestic market bhi 10.1% up hai. Government bhi PLI schemes se API self-sufficiency par kaam kar rahi hai. Long-term mein, apna pharma sector strong hi rahega.